Tisagenlecleucel: neurotoxicity and cytokine release syndrome

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1720卷 / 1期

关键词：

D O I：

10.1007/s40278-018-51809-6

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：15 / 15

相关论文

共 50 条

[41] Understanding cytokine release syndrome
Goedel, Philipp
Shimabukuro-Vornhagen, Alexander
von Bergwelt-Baildon, Michael
INTENSIVE CARE MEDICINE, 2018, 44 (03) : 371 - 373
[42] BelimumabSeizures and cytokine release syndrome
Reactions Weekly, 2024, 2003 (1) : 164 - 164
[43] Rituximab and Cytokine Release Syndrome
Kulkarni, Hrishikesh S.
Kasi, Pashtoon Murtaza
CASE REPORTS IN ONCOLOGY, 2012, 5 (01): : 134 - 140
[44] Modeling cytokine release syndrome
Cliona Rooney
Tim Sauer
Nature Medicine, 2018, 24 : 705 - 706
[45] Understanding cytokine release syndrome
Philipp Gödel
Alexander Shimabukuro-Vornhagen
Michael von Bergwelt-Baildon
Intensive Care Medicine, 2018, 44 : 371 - 373
[46] MB-CART19.1Cytokine release syndrome and immune effector cell–associated neurotoxicity syndrome: 11 case reports
Reactions Weekly, 2025, 2048 (1) : 229 - 229
[47] Multiple drugsLack of efficacy, cytokine release syndrome and immune effector cell-associated neurotoxicity syndrome: 3 case reports
Reactions Weekly, 2021, 1872 (1) : 353 - 353
[48] Multiple drugsImmune effector cell-associated neurotoxicity syndrome, cytokine release syndrome and lack of efficacy : 4 case reports
Reactions Weekly, 2023, 1980 (1) : 264 - 264
[49] Brexucabtagene-autoleucel/ibrutinib/lenalidomideLack of efficacy, cytokine release syndrome and Immune effector cell-associated neurotoxicity syndrome
Reactions Weekly, 2024, 1995 (1) : 46 - 46
[50] Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
Xiao, Xinyi
Huang, Shengkang
Chen, Sifei
Wang, Yazhuo
Sun, Qihang
Xu, Xinjie
Li, Yuhua
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2021, 40 (01)

← 1 2 3 4 5 →